HIGHLIGHTS
- who: Giovanni Monteleone from the Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy, *Gastroenterology Unit, Policlinico Tor have published the Article: Interleukin-34 Mediates Cross-Talk Between Stromal Cells and Immune Cells in the Gut, in the Journal: (JOURNAL)
- future: The future work will provide the necessary insight into whether IL-34 can be exploited as a therapeutic target for attenuating the detrimental immune and fibrotic responses in patients with IBD. Nonetheless further studies are necessary to explore the role of both IL-34 and M-CSF-1 in additional models of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.